Disease | laryngeal carcinoma |
Comorbidity | C0007137|squamous cell carcinoma |
Sentences | 19 |
PubMedID- 22558078 | High expression, as detected by western blotting, correlates with worse patient outcome for breast, small cell lung carcinoma, squamous cell carcinoma of the larynx and adenocortical tumors. |
PubMedID- 25692986 | Between march 2005 and april 2012, 139 patients with squamous cell carcinoma of the larynx were diagnosed and treated in the department of otorhinolaryngology, head and neck surgery, at yokohama city university hospital, japan. |
PubMedID- 24108458 | 1comparable image quality, fusion quality, lesion conspicuity and anatomic location by pet/ct and pet/mr in a 50-year-old woman with squamous cell carcinoma of the larynx t3n1m0. |
PubMedID- 20978630 | Squamous cell carcinoma of the larynx is the most common tumor accompanying laryngoceles, but there have been no reports of laryngoceles occurring because of a laryngeal schwannoma. |
PubMedID- 21718594 | Prognostic factor significance was evaluated among patients with squamous cell carcinoma of the larynx after treatment with primary surgery and prt. |
PubMedID- 20187979 | Whereas squamous cell carcinoma of the larynx has similar metastatic patterns to head and neck cancer in general, the incidence of metastases may be slightly lower [13]. |
PubMedID- 22958961 | The patient underwent total laryngectomy for advanced squamous cell carcinoma of the larynx eighteen months before this admission. |
PubMedID- 24711678 | The exclusion criteria were insufficient clinical information, previous treatment with radiotherapy or chemotherapy and oncologic diagnoses other than squamous cell carcinoma of the larynx. |
PubMedID- 22916151 | We identified 27 patients with loco-regionally advanced invasive squamous cell carcinoma of the larynx treated at the university of arizona radiation oncology department from 2007 to 2010. median age at diagnosis was 63 years-old (range: 52–84 years-old). |
PubMedID- 20576118 | Patient a, male, aged 42, had a well differentiated squamous cell carcinoma of the larynx, staged t2n0m0. |
PubMedID- 20588277 | Table 1 lists the cell lines used in this study, which were all derived from patients with primary squamous cell carcinoma of the larynx with the exception of um-scc-12 (recurrence after primary surgery). |
PubMedID- 24138811 | In squamous cell carcinoma of the larynx, sullu et al. |
PubMedID- 22453126 | Analyses restricted to patients with a histologically confirmed squamous cell carcinoma of the larynx revealed similar results (data not shown). |
PubMedID- 19830503 | Except for one female patient with a squamous cell carcinoma of the larynx more than 20 years earlier, no patient had previous cancer or received cancer-related chemo- or radiotherapy. |
PubMedID- 21457554 | Human head and neck tumor cell line hep-2 (squamous cell carcinoma of the larynx) was obtained from atcc, while cal 27 (squamous cell carcinoma of the tongue, atcc) were a kind donation of dr. jeannine gioanni, centre antoine lacasagne, nice, france. |
PubMedID- 24240099 | As with squamous cell carcinoma of the larynx, smoking is a recognized risk factor[17]. |
PubMedID- 20796303 | Criteria for inclusion were t1n0 or t2n0 squamous cell carcinoma of the larynx. |
PubMedID- 21208415 | 82 patients with stage iii/iv squamous cell carcinoma of the larynx, oropharynx, or hypopharynx, who underwent successful definitive (n = 63, mean dose 68.9gy) or postoperative (n = 19, mean dose 64.2gy) simultaneous integrated boost (sib) -imrt either alone or in combination with chemotherapy (85%) with curative intent between january 2002 and november 2005, were evaluated retrospectively. |
PubMedID- 20105339 | Laryngectomy was done due to t3 or t4 squamous cell carcinoma of the larynx or hypopharynx. |
Page: 1